Skip to main content
. 2017 Jun 8;32(3):e22276. doi: 10.1002/jcla.22276

Figure 4.

Figure 4

(A) Receiver operating characteristic curve for anti‐PGL1 IgA. Fifty‐four serum samples from leprosy patients were tested. (B) Receiver operating characteristic curve for anti‐PGL1 IgM. Fifty‐four serum samples from leprosy patients were tested.(C) Receiver operating characteristic curve for anti‐PGL1 IgG. Fifty‐four serum samples from leprosy patients were tested